We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cannabis Causes Structural Brain Changes in Adolescents

By HospiMedica International staff writers
Posted on 04 Jun 2019
A new study demonstrates that just one or two episodes of cannabis use during adolescence can result in changes in gray matter volume (GMV).

Researchers at the University of Vermont (UVM, Burlington, USA), Trinity College Dublin (Ireland), Technische Universität Dresden (TUD; Germany), and other institutions used voxel-based magnetic resonance imaging (MRI) morphometry to compare GMV in 46 14-year-old adolescents who reported just one or two instances of cannabis use, and who were carefully matched Δ-9-tetrahydrocannabinol (THC)-naive controls. More...
The MRI scans found that GMV was altered in relation to early exposure to cannabis.

The changes were seen in parts of the brain that have greater expression of CB1 receptors. Extensive regions were identified in the bilateral medial temporal lobes as well as the bilateral posterior cingulate, lingual gyri, and cerebellum. An analysis of longitudinal data confirmed that the GMV differences seen were unlikely to precede cannabis use. GMV in the temporal regions of the adolescent cannabis users was also associated with poorer performance on the Perceptual Reasoning Index, as well as with future generalized anxiety symptoms. The study was published on March 6, 2019, in the Journal of Neuroscience.

“There was an impact on the striatum and the insula in 14-year-olds who only had one or two exposures to marijuana. Since this effect was not seen in a separate group of adolescents who had one or two exposures by the age of 16, it looks as if exposure, even very little exposure, to cannabis before the age of 14 may have significant toxic effects,” said study co-author Scott Mackey, PhD, of UMV. “It is precisely now, when the movement to legalize cannabis is sweeping across the continent, that we need more research to inform our decision-making about the regulation of cannabis.”

Adolescent cannabis use is a well-known risk factor for psychosis; cannabis use in adults with a history of psychosis is a risk factor for relapse of psychosis; and exposure to cannabis can produce mild psychotic symptoms, such as paranoia. It is not known, however, if cannabis use is the cause of these outcomes or the result of other underlying factors such as early adversity, stress, or genetic predisposition toward dopamine dysregulation. Data show that close to 35% of U.S. students in grade 10 have reported using cannabis.

Related Links:
University of Vermont
Trinity College Dublin
Technische Universität Dresden


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Vessel Sealing Instrument
ERGOseal
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.